IGBA outlines 2019 achievements as Hanan Sboul takes over chairmanship

IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, has announced that Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers, is taking over the position of IGBA chairman for 2020 from Jim Keon, president of the Canadian Generic Pharmaceutical Association and Biosimilars Canada.

Key milestones were achieved for the IGBA during 2019, namely the signature of a memorandum of understanding with the World Health Organization (WHO) to promote access and the adoption by the International Council for Harmonization (ICH) of a new topic proposal on bioequivalence.

“The WHO agreement underscores the importance of generic and biosimilar medicines to increasing worldwide patient access to safe, effective and high-quality affordable medicines and the ICH developments demonstrate the importance of global harmonization of standards to support global development of generic medicines and competitiveness” commented the outgoing Mr Keon.